UPDATE 2-J&J tops estimates on strong prescription drug sales

April 16 (Reuters) - Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had been recalled over quality control problems.